PT Tempo Scan Pacific Tbk

TSPC

ID1000104508

Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
1,990 ^IDR	+0.76%		-1.97%	+8.45%

01/05	PT Tempo Scan Pacific Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
28/03	PT Tempo Scan Pacific Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PT Bogamulia Nagadi acquired an additional 0.01% stake in PT Tempo Scan Pacific Tbk for approximately IDR 640 million.

May 28, 2015

PT Bogamulia Nagadi acquired an additional 0.01% stake in PT Tempo Scan Pacific Tbk (JKSE:TSPC) for approximately IDR 640 million on May 20, 2015. PT Bogamulia Nagadi acquired 0.31 million shares for IDR 2070 per share.

PT Bogamulia Nagadi completed the acquisition of an additional 0.01% stake in PT Tempo Scan Pacific Tbk (JKSE:TSPC) on May 20, 2015.

Latest news about PT Tempo Scan Pacific Tbk

PT Tempo Scan Pacific Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	01/11	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	01/23/01	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	29/23/29	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	16/22/16	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	12/22/12	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	31/22/31	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	29/21/29	CI
PT Tempo Scan Pacific Tbk Reports Earnings Results for the Half Year Ended June 30, 2021	31/21/31	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the First Quarter Ended March 31, 2021	03/21/03	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the Full Year Ended December 31, 2020	31/21/31	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020	02/20/02	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the Half Year Ended June 30, 2020	30/20/30	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the First Quarter Ended March 31, 2020	29/20/29	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the Nine Months Ended September 30, 2019	31/19/31	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the Half Year Ended June 30, 2019	31/19/31	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the First Quarter Ended March 31, 2019	29/19/29	CI
Pt Tempo Scan Pacific Tbk Reports Earnings Results for the Full Year Ended December 31, 2018	29/19/29	CI
PT Tempo Scan Pacific Tbk(JKSE:TSPC) dropped from S&P Global BMI Index	19/16/19	CI
PT Tempo Scan Pacific Tbk Reports Consolidated Earnings Results for the First Semester of 2015	30/15/30	CI
PT Tempo Scan Pacific Tbk(JKSE:TSPC) dropped from Russell Global Index	29/15/29	CI
PT Bogamulia Nagadi acquired an additional 0.01% stake in PT Tempo Scan Pacific Tbk for approximately IDR 640 million.	28/15/28	CI

Chart PT Tempo Scan Pacific Tbk

Duration

Period

More charts

Company Profile

PT Tempo Scan Pacific Tbk is an Indonesia-based company engaged in the industry of pharmaceuticals, consumer products and cosmetics. The Companyâs segments include Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment conducts marketing of consumer health products consisting of over the counter; vitamin, mineral and supplement (VMS) and beverage products; nutritional products and herbal products; and prescription medicine products. The Consumer Products and Cosmetics segment markets and distributes own branded products as well as licensed cosmetics products. The Distribution Services segment distributes products to customers. The segment serves customers from various sales branches throughout Indonesia, covering pharma, modern trade, and general trade channels. It also markets and distributes its products overseas through its international business units. Its business network covers about 220 locations that consist of 47 branches.

Sector

Pharmaceuticals

Calendar

05/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PT TEMPO SCAN PACIFIC TBK	+8.45%	552M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B